142 related articles for article (PubMed ID: 36975499)
1. Evaluation of the Efficacy of Immune and Inflammatory Markers in the Diagnosis of Lacrimal-Gland Benign Lymphoepithelial Lesion.
Luan F; Liu R; Li J; Ge X; Wang N; Guo Q; Tao Y; Ma J
Curr Issues Mol Biol; 2023 Mar; 45(3):2013-2020. PubMed ID: 36975499
[TBL] [Abstract][Full Text] [Related]
2. Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion.
Liu R; Wang N; Wang JJ; Li J; Ge X; Zhang JX; Ma JM
Int J Ophthalmol; 2023; 16(6):876-883. PubMed ID: 37332559
[TBL] [Abstract][Full Text] [Related]
3. B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.
Wang XN; Ge X; Li J; Liu X; Ma JM
Int J Ophthalmol; 2017; 10(5):665-669. PubMed ID: 28546918
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance.
Zhang XJ; Zhao PX; Ma MS; Wu H; Liu R; Wang H; Liu MY; Xie F; Ma XM
Int J Ophthalmol; 2023; 16(11):1734-1745. PubMed ID: 38028530
[TBL] [Abstract][Full Text] [Related]
5. The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.
Li J; Liu R; Sun M; Wang J; Wang N; Zhang X; Ge X; Ma J
Sci Rep; 2021 Nov; 11(1):21853. PubMed ID: 34750466
[TBL] [Abstract][Full Text] [Related]
6. Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.
Zhang X; Zhao P; Ma M; Wu H; Liu R; Liu Z; Cai Z; Liu M; Xie F; Ma X
Front Med (Lausanne); 2023; 10():1168977. PubMed ID: 37457559
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features and Prognoses of IgG4-Positive and IgG4-Negative Lacrimal Lymphomas.
Liu R; Wang J; Wang N; Li J; Ge X; Zhang J; Ma J
Front Oncol; 2021; 11():622847. PubMed ID: 33763358
[No Abstract] [Full Text] [Related]
8. Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients.
Ma JM; Li J; Ge X; Li M; Li JR; Wang XN
Chin Med J (Engl); 2015 Feb; 128(4):493-8. PubMed ID: 25673452
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland].
Li HQ; Lin JY; Zhao H
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680
[No Abstract] [Full Text] [Related]
10. Lacrimal Gland and Orbital Lesions in Lat
Hamaoka S; Takahira M; Kawano M; Yamada K; Ito K; Okuda T; Hatake S; Malissen M; Malissen B; Sugiyama K
Curr Eye Res; 2022 Oct; 47(10):1405-1412. PubMed ID: 35913026
[TBL] [Abstract][Full Text] [Related]
11. [The clinicopathological features of adult orbital xanthogranulomatous disease with lacrimal gland reactive lymphoid hyperplasia].
Wang YC; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2022 Sep; 58(9):682-687. PubMed ID: 36069088
[No Abstract] [Full Text] [Related]
12. IgG anti-hinge antibodies against IgG4 F(ab')
Ota T; Ota SI; Uchino A; Nagano S
Arthritis Res Ther; 2020 Jun; 22(1):161. PubMed ID: 32586370
[TBL] [Abstract][Full Text] [Related]
13. Association of the macrophage migration inhibitory factor promoter polymorphisms with benign lymphoepithelial lesion of lacrimal gland.
Li QJ; Zhao PX; Zhang XJ; Yi Y; Cheng DY; Ma JM; Ma XM
Int J Ophthalmol; 2017; 10(8):1229-1232. PubMed ID: 28861347
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Patterns and Predictors of the Functional Restoration of Immunoglobulin G4-Related Kidney Disease: A Chinese Single-Center Cohort Study.
Su T; Wang H; Wang S; Yang L
Front Med (Lausanne); 2021; 8():736098. PubMed ID: 34692728
[No Abstract] [Full Text] [Related]
15. Clinical Characteristics and CD4
Yang Y; Wang C; Shi L; Yang S; Liu Y; Luo J; Wang C
Front Immunol; 2022; 13():825386. PubMed ID: 35432312
[TBL] [Abstract][Full Text] [Related]
16. Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.
Ma JM; Cui YX; Ge X; Li J; Li JR; Wang XN
Int J Ophthalmol; 2015; 8(4):685-9. PubMed ID: 26309862
[TBL] [Abstract][Full Text] [Related]
17. Increased Immunoglobulin G4-positive Plasma Cells in Lymphadenoma of the Salivary Gland: An Immunohistochemical Comparison Among Lymphoepithelial Lesions.
Kim J; Song JS; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):420-424. PubMed ID: 27941558
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.
Zhang X; Zhang P; Peng L; Fei Y; Zhang W; Feng R; Zhang W
Clin Rheumatol; 2018 Dec; 37(12):3387-3395. PubMed ID: 29948354
[TBL] [Abstract][Full Text] [Related]
19. Evaluate the Differences in CT Features and Serum IgG4 Levels between Lymphoma and Immunoglobulin G4-Related Disease of the Orbit.
Yuan WH; Li AF; Yu SY; Chen YY; Wu CH; Hsu HC; Lirng JF; Guo WY
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751135
[TBL] [Abstract][Full Text] [Related]
20. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases.
Yamada K; Yamamoto M; Saeki T; Mizushima I; Matsui S; Fujisawa Y; Hara S; Takahashi H; Nomura H; Kawa S; Kawano M
Arthritis Res Ther; 2017 Dec; 19(1):262. PubMed ID: 29191210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
